Series A

Velaura AI hits a $1B valuation with a $110M round, betting its proven low-power chips can solve the AI industry's escalating energy crisis.

With a $30M Series A, Mindgard is turning a decade of university research into a new defense against AI's unique and complex vulnerabilities.

Turnout's new AI platform, fronted by Steve Harvey, aims to unlock $140B in government benefits. Is this a tech-for-good revolution or a savvy business play?

River AI, led by an xAI co-founder, has secured $1.1B to build an open AI stack, aiming to shift AI ownership from big labs to individual companies.

With $15B in deals, Volta is treating AI compute like electricity, aiming to build a new utility for an industry constrained by capital, not just chips.

As legacy data protection fails in the AI era, ORION Security's rapid growth signals a market shift. Is their 'agentic' AI the answer to alert fatigue?

With a $17M Series A and Dot's Pretzels' former CEO Randy Johnson at the helm, The Farmer Companies is betting big on its plan to dominate the premium cheese snack market.

A $10M Series A fuels Discern's mission to automate a high-stakes, overlooked corner of corporate operations. Here's why investors see it as essential infrastructure.

A Columbus startup just raised $18M to exploit a flaw in employer healthcare, saving dual-income families thousands by turning a costly bug into a feature.

A new biotech, CORE Biomedicine, armed with Eisai's preclinical assets and a $21M Series A, aims to upend oncology by targeting cancer's 'lineage' identity.

With $21M in funding and a novel 'lineage-based' approach, CORE Biomedicine is moving beyond genomics to target the root cause of cancer's identity.

As AI-driven attacks operate at machine speed, one startup is betting $60M that reactive security is obsolete. Act Security aims to eliminate threats, not just find them.

With a $34M Series A, Paper is building a new design paradigm where AI agents don't just assist, but initiate creative work, blurring the line between code and canvas.

As AI divides the gaming world, Hyderabad's Liquidnitro Games hires a top ex-Tencent CTO, betting its $24.3M in funding on a bold new model: AI that amplifies human creativity.

With $8M in new funding, Tikva Allocell is advancing a novel cell therapy that uses armored, virus-specific T cells to overcome historical barriers in cancer.

Houston-based TYBR Health lands $30M to scale its B3 GEL System, a novel hydrogel aiming to shift orthopedic surgery from mere repair to managed recovery.

How a 25-year-old Canadian superfood brand secured $10.5M to tackle the U.S. market, blending a rich legacy with functional nutrition innovation.

Alocity's Series A funding signals a shift in physical security. Their AI, Aimee, talks to existing systems, aiming to make complex dashboards obsolete.

A startup less than a year old just raised $30M to build financial rails for AI agents. We look inside Natural's plan to power the coming agentic economy.

DocJuris launches Workforce, an AI service aiming to complete legal tasks, not just assist. Is this the end of AI's 'last mile' problem for in-house teams?